NATCO Pharma

NATCO Pharma

NATCOPHARM

 ₹ 1,347.33
- ₹ 16.33
1.20%
Healthcare
 ₹ 0.00
(%)1D
Updated: 24 Dec 2024, 03:31:10 pm IST
Stock Score
Open Price
 ₹ 1,370.30
Prev. Close
 ₹ 1,363.66
 ₹ 1,342.91
Day Low
 ₹ 1,375.21
Day High

 ₹ 759.05
52 Week Low
 ₹ 1,631.22
52 Week High

Quick Bite

Price To Earnings Ratio

17.37

Sector PE

69.70

PB Ratio

4.12

Sector PB

8.89

EPS

77.56

Dividend Yield

1.00

Today's Volume

345.625 K

5 Day Avg. Volume

628.168 K

PEG Ratio

0.18

Market Cap.

₹ 25,380.00 Cr.

NATCO Pharma Share Price

Natco Pharma Limited is a vertically integrated R&D pharmaceutical company based in India. The company's field of activity is the pharmaceutical business, which includes research and development, production and sale of bulk drugs and ready-made medical preparations. The company produces ready-to-use dosage forms (FDFs), which it sells in India, the US and the rest of the world, and also produces active pharmaceutical ingredients (APIs). Its capabilities include multi-step synthesis, semi-synthetic splicing technologies, production of potent APIs and peptides. The company operates in two segments: Pharmaceuticals and Agricultural Chemicals. In the pharmaceutical industry, the Company channels its sales through FDFs and APIs. The agrochemicals segment focuses on specialty products, including pest control.

NATCO Pharma FAQs

How to Buy NATCO Pharma Share?

up
To purchase NATCO Pharma shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for NATCO Pharma (ticker symbol: NATCOPHARM) on the trading platform provided by your broker and purchase the shares.

What's NATCO Pharma share price today?

up
The stock price of NATCO Pharma as of 25 Dec 2024 is ₹1,347.33

What is the Market Cap of NATCO Pharma?

up
Market capitalisation represents the total market value of a company's outstanding shares. As of 25 Dec 2024, NATCO Pharma (ticker symbol: NATCOPHARM) has a market capitalisation of approximately ₹2,53,80,00,00,000.00

What is the PE and PB ratio of NATCO Pharma?

up
NATCO Pharma Ltd's price-to-book ratio as of 25 Dec 2024 is 4.12, reflecting the market's valuation compared to its asset value. As of 25 Dec 2024, the trailing twelve months P/E (price-to-earnings) ratio is 17.37, indicating the market values the company at around ₹17.37 for every ₹1 of earnings

What is the 52 Week High and Low of NATCO Pharma Share?

up
NATCO Pharma Ltd (NATCOPHARM) hit its 52-week high at ₹1,631.22, and its 52-week low at ₹759.05.
Want to learn and earn in Stocks?
Login/Register
Start Learning